# Artelon

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/artelon

- Industry: Medical Devices & Equipment
- Headquarters: Marietta, US
- Website: www.artelon.com
- Total disclosed funding: $20M
- Latest round: Series B (May 19, 2023)
- Investors on record: 1

## About

Founded in 2013 and based in Georgia, US, Artelon, Inc. operates as a medical device company that provides equipment for tendon and ligament injuries. The company was founded by Lars Peterson. In May 2023, Artelon raised USD 20 million in Series B funding led by Vensana Capital. As of 2023, the company is led by its CEO, Aaron Smith.

Artelon manufactures a wide range of medical equipment called Artelon® FlexBand, which is a biomaterial that consists of synthetic and natural polymers that are used in a variety of surgical procedures to reinforce and stabilize soft tissues, ligaments, and muscles; Artelon FlexPatch, a patch that is used to repair and reconstruct soft tissues; Artelon FlexBand Plus Tissue Reinforcement, which is used to reinforce soft tissue during surgery; Flexband® SOLO and Flexband MULTI products. Additionally, the company provides Dynamic Matrix® technology for musculoskeletal soft tissue reconstruction, which aids in promoting the regeneration and healing of injured or damaged soft tissues.

The company plans to use the funds raised in May 2022 to support its growth, clinical research, and product expansion.

## Funding rounds

- Series B, May 19, 2023, $20M — Vensana Capital

## Investors

- Vensana Capital (https://capitalatlas.ai/funds/vensana-capital) — Series B